EP3824905
AÐFERÐIR OG SAMSETNINGAR TIL ÓNÆMINGAR Í FRUMUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.8.2013EP published:
8.1.2025EP application number:
20201497.3
EP translation filed:
17.3.2025Grant published:
15.4.2025EPO information:
European Patent Register
Max expiry date:
19.8.2033Expiry date:
19.8.2026Next due date:
31.8.2026
Title in English:
METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPYLanguage of the patent:
English
Timeline
Today
20.8.2013EP application
8.1.2025EP Publication
17.3.2025Translation submitted
15.4.2025Registration published
19.8.2026Expires
Owner
Name:
Fred Hutchinson Cancer CenterAddress:
1100 Fairview Avenue North, Seattle, WA 98109, US
Name:
Seattle Children's Hospital, dba Seattle Children's Research InstituteAddress:
1900 9th Avenue, Seattle, WA 98101, US
Inventor
Name:
Riddell, Stanley R.Address:
Sammamish, WA 98075, US
Name:
Hudecek, MichaelAddress:
04107 Leipzig, DE
Name:
Jensen, MichaelAddress:
Bainbridge Island, WA 98110, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201261691117 PDate:
20.8.2012Country:
US
Classification
Categories:
C07K 14/705, C07K 14/715, C07K 14/725, C07K 16/32, C07K 16/28, C07K 19/00, A61P 1/00, A61P 1/04, A61P 1/18, A61P 11/00, A61P 13/08, A61P 13/12, A61P 15/00, A61P 31/12, A61P 35/00, A61P 35/02, A61P 37/02, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 13.8.2025
Expires: 19.8.2026
Payer: Árnason Faktor ehf.